These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38845590)

  • 1. Type-2 severe asthma comorbidities in the era of biologics: time to rethink clinical response?
    Portacci A; Dragonieri S; Carpagnano GE
    Expert Rev Respir Med; 2024 May; 18(5):249-253. PubMed ID: 38845590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.
    Weinstein SF; Katial RK; Bardin P; Korn S; McDonald M; Garin M; Bateman ED; Hoyte FCL; Germinaro M
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):589-596.e3. PubMed ID: 30193936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Severe Asthma Network in Italy: Findings and Perspectives.
    Heffler E; Blasi F; Latorre M; Menzella F; Paggiaro P; Pelaia G; Senna G; Canonica GW;
    J Allergy Clin Immunol Pract; 2019; 7(5):1462-1468. PubMed ID: 30368004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologics and Bronchial Thermoplasty for severe refractory asthma treatment: From eligibility criteria to real practice. A cross-sectional study.
    Menzella F; Galeone C; Ruggiero P; Bagnasco D; Catellani C; Facciolongo N
    Pulm Pharmacol Ther; 2020 Feb; 60():101874. PubMed ID: 31857207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 severe asthma: pathophysiology and treatment with biologics.
    Pelaia C; Melhorn J; Hinks TS; Couillard S; Vatrella A; Pelaia G; Pavord ID
    Expert Rev Respir Med; 2024 Jul; 18(7):485-498. PubMed ID: 38994712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Effectiveness of IL-5/5Ra Targeted Biologics in Severe Eosinophilic Asthma With Comorbid Bronchiectasis.
    Bendien SA; Kroes JA; van Hal LHG; Braunstahl GJ; Broeders MEAC; Oud KTM; Patberg KW; Smeenk FWJM; van Veen IHPAA; Weersink EJM; Fieten KB; Hashimoto S; van Veen A; Sont JK; van Huisstede A; van de Ven MJT; Langeveld B; Maitland-van der Zee AH; Ten Brinke A;
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2724-2731.e2. PubMed ID: 37295671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe T2-high asthma in the biologics era: European experts' opinion.
    Pavord I; Bahmer T; Braido F; Cosío BG; Humbert M; Idzko M; Adamek L
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry.
    Canonica GW; Malvezzi L; Blasi F; Paggiaro P; Mantero M; Senna G; Heffler E;
    Respir Med; 2020 May; 166():105947. PubMed ID: 32250875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
    Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
    Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission.
    Carpagnano GE; Portacci A; Nolasco S; Detoraki A; Vatrella A; Calabrese C; Pelaia C; Montagnolo F; Scioscia G; Valenti G; D'Amato M; Caiaffa MF; Triggiani M; Scichilone N; Crimi C
    Front Immunol; 2024; 15():1343362. PubMed ID: 38327518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Biologics in the Treatment of Nasal Polyps.
    Franzese CB
    Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life studies of biologics used in asthma patients: key differences and similarities to trials.
    Heffler E; Paoletti G; Giorgis V; Puggioni F; Racca F; Del Giacco S; Bagnasco D; Caruso C; Brussino L; Rolla G; Canonica GW
    Expert Rev Clin Immunol; 2019 Sep; 15(9):951-958. PubMed ID: 31389304
    [No Abstract]   [Full Text] [Related]  

  • 13. EUFOREA consensus on biologics for CRSwNP with or without asthma.
    Fokkens WJ; Lund V; Bachert C; Mullol J; Bjermer L; Bousquet J; Canonica GW; Deneyer L; Desrosiers M; Diamant Z; Han J; Heffler E; Hopkins C; Jankowski R; Joos G; Knill A; Lee J; Lee SE; Mariën G; Pugin B; Senior B; Seys SF; Hellings PW
    Allergy; 2019 Dec; 74(12):2312-2319. PubMed ID: 31090937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Otitis media in severe asthma associated with chronic rhinosinusitis with nasal polyps: a new therapeutic target for biologics.
    Bartier S; Béquignon E; Thibaut de Ménonville C; Verillaud B; Evrard D; Léger M; Papon JF; Coste A; Taillé C
    J Asthma; 2023 Jan; 60(1):139-144. PubMed ID: 35073225
    [No Abstract]   [Full Text] [Related]  

  • 15. Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study.
    Bidder T; Sahota J; Rennie C; Lund VJ; Robinson DS; Kariyawasam HH
    Rhinology; 2018 Mar; 56(1):42-45. PubMed ID: 29288573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era.
    Mullol J; Azar A; Buchheit KM; Hopkins C; Bernstein JA
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1434-1453.e9. PubMed ID: 35306180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of biologics in chronic rhinosinusitis: a systematic review.
    Iqbal IZ; Kao SS; Ooi EH
    Int Forum Allergy Rhinol; 2020 Feb; 10(2):165-174. PubMed ID: 31869863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe asthma management in the era of biologics: insights of the Italian Registry on Severe Asthma (IRSA).
    Bilò MB; Antonicelli L; Carone M; De Michele F; Menzella F; Musarra A; Tognella S; Vaghi A; Micheletto C
    Eur Ann Allergy Clin Immunol; 2021 May; 53(3):103-114. PubMed ID: 33728838
    [No Abstract]   [Full Text] [Related]  

  • 19. Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis.
    Bisaccioni C; Aun MV; Cajuela E; Kalil J; Agondi RC; Giavina-Bianchi P
    Clinics (Sao Paulo); 2009; 64(8):769-73. PubMed ID: 19690661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy.
    Maniaci A; Saibene AM; Calvo-Henriquez C; Vaira L; Radulesco T; Michel J; Chiesa-Estomba C; Sowerby L; Lobo Duro D; Mayo-Yanez M; Maza-Solano J; Lechien JR; La Mantia I; Cocuzza S
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):2167-2173. PubMed ID: 38329526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.